
Pyrotinib-Based Therapy May Improve Survival in Patients With HER2+ Breast Cancer and Liver Metastases
Pyrotinib-based therapy demonstrated efficacy and safety in the treatment of patients with human epidermal growth factor receptor 2-positive (HER2+) advanced metastatic breast cancer (mBC) with liver metastases, according to study findings published in …